Drug monopoly extension splits EU ministers in Biotech Act debate

EU health ministers split over a proposal to give certain innovative medicines an extra year of market protection, with EU Health Commissioner arguing the incentive is needed to keep biotech investment in Europe. Incoming Irish presidency, in the meantime, says it will work as quickly as possible.

This story was reported by Latest News From Euronews | Euronews RSS. EUROPES curates Europe's most relevant coverage — read the full report at the original source.